You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Article metrics

Article menu

Download PDFPDF

XML
Position article and guidelines
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

 

Online download statistics by month:

Online download statistics by month: July 2020 to August 2025

AbstractFullPdf
Jul 202036537191
Aug 202015615736
Sep 2020909031
Oct 2020737326
Nov 2020767626
Dec 2020787823
Jan 202111211222
Feb 202113113158
Mar 202117317338
Apr 202112512547
May 2021727247
Jun 2021838143
Jul 202110110143
Aug 2021818132
Sep 2021707024
Oct 2021747431
Nov 2021747440
Dec 2021747528
Jan 2022667432
Feb 2022839830
Mar 2022465131
Apr 202213214431
May 2022999928
Jun 20229910230
Jul 202211711834
Aug 202210410545
Sep 202211211768
Oct 202210811749
Nov 2022888828
Dec 2022707120
Jan 2023828215
Feb 2023929229
Mar 2023969837
Apr 2023919420
May 2023727327
Jun 2023818121
Jul 202311011128
Aug 2023656517
Sep 2023858844
Oct 202318018024
Nov 2023969731
Dec 2023717222
Jan 2024404020
Feb 202413713823
Mar 202411611792
Apr 2024939432
May 2024808120
Jun 2024697022
Jul 2024666720
Aug 2024454418
Sep 2024404020
Oct 2024606131
Nov 2024949530
Dec 2024717220
Jan 2025656525
Feb 202512012019
Mar 2025858624
Apr 202510010024
May 2025676816
Jun 2025767721
Jul 2025220
Aug 2025110
Total568057691904